Medtronic Reports Q4 Revenue and Adjusted EPS Above Expectations Amid FX Headwinds

Gelonghui May 23 | Irish medical device company Medtronic announced its fourth-quarter earnings for the fiscal year ended April 26. The adjusted earnings per share were $1.46, down from $1.57 in the same period last year but slightly higher than the analysts' expected $1.45. Despite facing a $72 million headwind from foreign exchange, revenue increased slightly by 0.5% to $8.59 billion, surpassing the analysts' expected $8.44 billion. Medtronic expects that for the fiscal year 2025, the adjusted earnings per share will be between $5.4 and $5.5. Based on current interest rates, foreign currencies will have a 5% negative impact. Medtronic executives stated that revenue growth in emerging markets has been unstable over the past few years, but these fundamentals are returning.